SEARCH

SEARCH BY CITATION

References

  • Ali, M., Fayemi, A.O., Rigolosi, R., Frascino, J., Marsden, T. & Malcolm, D. (1980) Hemosiderosis in hemodialysis patients. An autopsy study of 50 cases. Journal of the American Medical Association, 244, 343345.
  • Ali, M., Rigolosi, R., Fayemi, A.O., Braun, E.V., Frascino, J. & Singer, R. (1982) Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy. Lancet, 1, 652655.
  • Arndt, U., Kaltwasser, J.P., Gottschalk, R., Hoelzer, D. & Moller, B. (2005) Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin. Annals of Hematology, 84, 159166.
  • Barron, B.A., Hoyer, J.D. & Tefferi, A. (2001) A bone marrow report of absent stainable iron is not diagnostic of iron deficiency. Annals of Hematology, 80, 66169.
  • Brugnara, C. (2003) Iron deficiency and erythropoiesis: new diagnostic approaches. Clinical Chemistry, 49, 15731578.
  • Brugnara, C., Schiller, B. & Moran, J. (2006) Reticulocyte haemoglobin content (Ret He) and assessment of iron-deficient states. Clinical and Laboratory Haematology, 28, 303308.
  • Buhrmann, E., Mentzer, W.C. & Lubin, B.H. (1978) The influence of plasma bilirubin on zinc protoporphyrin measurement by a hematofluorimeter. Journal of Laboratory and Clinical Medicine, 91, 710716.
  • Buttarello, M., Pajola, R., Novello, E., Rebeschini, M., Cantaro, S., Oliosi, F., Naso, A. & Plebani, M. (2010) Diagnosis of iron deficiency in patients undergoing hemodialysis. American Journal of Clinical Pathology, 133, 949954.
  • Canals, C., Remacha, A.F., Sarda, M.P., Piazuelo, J.M., Royo, M.T. & Romero, M.A. (2005) Clinical utility of the new Sysmex XE2100 parameter – reticulocyte hemoglobin equivalent – in the diagnosis of anemia. Hematologica, 90, 11331134.
  • Cavill, I. (1999) Iron status as measured by serum ferritin: the marker and its limitations. American Journal of Kidney Disease, 34 (Suppl. 2), S12S17.
  • Cazzola, M., Ponchio, L., Beguin, Y., Rosti, V., Bergamaschi, G., Liberato, N.L., Fregoni, V., Nalli, G., Barosi, G. & Ascari, E. (1992) Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood, 79, 2937.
  • Chen, Y.C., Hung, S.C. & Tarng, D.C. (2006) Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. American Journal of Kidney Disease, 47, 10361044.
  • Chiang, W.C., Tsai, T.J., Chen, Y.M., Lin, S.L. & Hsieh, B.S. (2002) Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients. Clinical Nephrology, 58, 363369.
  • Chuang, C.L., Liu, R.S., Wei, Y.H., Huang, T.P. & Tarng, D.C. (2003) Early prediction of response to intravenous iron supplementation by reticulocyte hemoglobin content and high-fluorescence reticulocyte count in hemodialysis patients. Nephrology Dialysis Transplantation, 18, 370377.
  • Cook, J.D. & Skikne, B.S. (1982) Serum ferritin: a possible model for the assessment of nutrient stores. American Journal of Clinical Nutrition, 35, S1180S1185.
  • Coyne, D.W. (2011) Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney International, 80, 240244.
  • Coyne, D.W., Kapoian, T., Suki, W., Singh, A.K., Moran, J.E., Dahl, N.V. & Rizkala, A.R. (2007) Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV iron with Elevated Ferritin (DRIVE) study. Journal of the American Society of Nephrology, 18, 975984.
  • Davies, B.H. (1996) Immature reticulocyte fraction (IRF): by any name a useful clinical parameter. Laboratory Hematology, 2, 28.
  • Dukkipati, R. & Kalantar-Zadeh, K. (2007) Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients? Nephrology News Issues, 21, 3438.
  • Ferguson, B.J., Skikne, B.S., Simpson, K.M., Baynes, R.D. & Cook, J.D. (1992) Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. Journal of Laboratory and Clinical Medicine, 119, 385390.
  • Fernandez-Rodriguez, A.M., Guindeo-Casasus, M.C., Molero-Labarta, T., Dominguez-Cabrera, C., Hortal-Casc n, L., Perez-Borges, P., Vega-Diaz, N., Saavedra-Santana, P. & Palop-Cubillo, L. (1999) Diagnosis of iron deficiency in chronic renal failure. American Journal of Kidney Disease, 34, 508513.
  • Fishbane, S. & Maessaka, J.K. (1997) Iron management in end-stage renal failure. American Journal of Kidney Disease, 29, 319333.
  • Fishbane, S., Shapiro, W., Dutka, P., Valenzuela, O.F. & Faubert, J. (2001) A randomised trial of iron deficiency testing strategies in haemodialysis patients. Kidney International, 60, 24062411.
  • Ganz, T. (2007) Molecular control of iron transport. Journal of the American Society of Nephrology, 18, 394400.
  • Garrett, S. & Worwood, M. (1994) Zinc protoporphyrin and iron-deficient erythropoiesis. Acta Haematologica, 91, 2125.
  • Garzia, M., Di Mario, A., Ferraro, E., Tazza, L., Rossi, E., Luciani, G. & Zini, G. (2007) Reticulocyte haemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy. Laboratory Hematology, 13, 611.
  • Goodnough, L.T., Nemeth, E. & Ganz, T. (2011) Detection, evaluation and management of iron-restricted erythropoiesis. Blood, 116, 47544761.
  • Graham, E.A., Felgenhauer, J., Detter, J.C. & Labbe, R.F. (1996) Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E. Journal of Pediatrics, 129, 105110.
  • Henry, D.H. Parenteral iron therapy in cancer-associated anemia (2010). Hematology American Society of Hematology Education Program, Haematology, 2010, 351356.
  • Henry, D.H., Brooks, B.J. Jr, Case, D.C. Jr, Fishkin, E., Jacobson, R., Keller, A.M., Kugler, J., Moore, J., Silver, R.T., Storniolo, A.M., Abels, R.I., Gordon, D.S., Nelson, R., Larholt, K., Bryant, E. & Rudnick, S. (1995) Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin therapy. Cancer Journal Scientific American, 1, 252260.
  • Hochberg, M.C., Arnold, C.M., Hogans, B.B. & Spivak, J.L. (1988) Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis and Rheumatism, 31, 13181321.
  • Huebers, H.A., Beguin, Y., Pootrakul, P., Einspahr, D. & Finch, C.A. (1990) Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood, 75, 102107.
  • Hughes, D.A., Stuart-Smith, S.E. & Bain, B.J. (2004) How should stainable iron in bone marrow films be assessed? Journal of Clinical Pathology, 57, 10381040.
  • Kalantar-Zadeh, K., Regidor, D.L., McAllister, C.J., Michael, B. & Warnock, D.G. (2005) Time-dependent associations between iron and mortality in hemodialysis patients. Journal of the American Society of Nephrology, 16, 30703080.
  • KDIGO (Kidney Disease: Improving Global Outcomes) Anemia Work Group (2012) Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International Supplements, 2, 283287.
  • Kohgo, Y., Niitsu, Y., Kondo, H., Kato, J., Tsushima, N., Sasaki, K., Hirayama, M., Numata, T., Nishisato, T. & Urushizaki, I. (1987) Serum transferrin receptor as a new index of erythropoiesis. Blood, 70, 19551958.
  • Koulaouzidis, A., Said, E., Cottier, R. & Saeed, A.A. (2009) Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. Journal of Gastrointestinal and Liver Disease, 18, 345352.
  • Lee, E.J., Oh, E.J., Park, Y.J., Lee, H.K. & Kim, B.K. (2002) Soluble transferrin receptor (sTfR) and sTfR/log ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. Clinical Chemistry, 48, 11181121.
  • Lippi, G., Salvagno, G.L., Solero, G.P., Franchini, M. & Guidi, G.C. (2005) Stability of blood cell counts, hematologic parameters and reticulocyte indexes on the Advia A120 hematologic analyser. Journal of Laboratory and Clinical Medicine, 146, 333340.
  • Littlewood, T.J., Zagari, M., Pallister, C. & Perkins, A. (2003) Baseline and early treatment factors are not clinically useful for predicting individual response to erythropoietin in anemic cancer patients. Oncologist, 8, 99107.
  • Ljung, T., Back, R. & Hellstrom-Lindberg, E. (2004) Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors. Haematologica, 89, 14461553.
  • Locatelli, F., Aljama, P., Barany, P., Canaud, B., Carrera, F., Eckardt, K.U., Horl, W.H., Macdougall, I.C., Macleod, A., Wiecek, A. & Cameron, S. European Best Practice Guidelines Working Group. (2004) Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrology Dialysis Transplantation, 19 (Suppl. 2):ii, 147.
  • Low, C.L., Bailie, G.R. & Eisele, G. (1997) Sensitivity and specificity of transferrin saturation and serum ferritin as markers of iron status after intravenous iron dextran in hemodialysis patients. Renal Failure, 19, 781788.
  • Macdougall, I.C., Hutton, R.D., Cavill, I., Coles, G.A. & Williams, J.D. (1989) Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. British Medical Journal, 299, 157158.
  • Macdougall, I.C., Hutton, R.D., Cavill, I., Coles, G.A. & Williams, J.D. (1990) Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm. British Medical Journal, 300, 655659.
  • Macdougall, I.C., Cavill, I., Hulme, B., Bain, B., McGregor, E., McKay, P., Sanders, E., Coles, G.A. & Williams, J.D. (1992) Detection of iron deficiency during erythropoietin treatment: a new approach. British Medical Journal, 304, 225226.
  • Macdougall, I.C., Malyszko, J., Hider, R.C. & Bansal, S.S. (2010) Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clinical Journal of the American Society of Nephrology, 5, 16811689.
  • Maconi, M., Cavalca, L., Danise, P., Cardarelli, F. & Brini, M. (2009) Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods. Scandinavian Journal of Clinical and Laboratory Investigation, 69, 365370.
  • Mast, A.E., Blinder, M.A., Gronowski, A.M., Chumley, C. & Scott, M.G. (1998) Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clinical Chemistry, 44, 4551.
  • Mast, A.E., Blinder, M.A., Lu, Q., Flax, S. & Dietzen, D.J. (2002) Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood, 99, 14891491.
  • Mast, A.E., Blinder, M.A. & Dietzen, D.J. (2008) Reticulocyte hemoglobin content. American Journal of Hematology, 83, 307310.
  • Matzkies, F.K., Cullen, P., Schaefer, L., Hartmann, M., Hohage, H. & Schaefer, R.M. (1999) Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndrome. Southern Medical Journal, 92, 11571161.
  • Means, R.T., Allen, J., Sears, D.A. & Schuster, S.J. (1999) Serum soluble transferrin receptor and the prediction of marrow iron results in a heterogeneous group of patients. Clinical and Laboratory Haematology, 21, 161167.
  • Miller, C.B., Jones, R.J., Piantadosi, S., Abeloff, M.D. & Spivak, J.L. (1990) Decreased erythropoietin response in patients with the anemia of cancer. New England Journal of Medicine, 322, 16891692.
  • Mittman, M., Sreedhara, R., Mushnick, R., Chattopadhyay, J., Zelmanovic, D., Vasghi, M. & Avram, M.M. (1997) Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. American Journal of Kidney Disease, 30, 912922.
  • Miwa, N., Akiba, T., Kimata, N., Hamaguchi, Y., Arakawa, Y., Tamura, T., Nitta, K. & Tsuchiya, K. (2010) Usefulness of measuring reticulocyte haemoglobin equivalent in the management of haemodialysis patients with iron deficiency. International Journal of Laboratory Haematology, 32, 248255.
  • National Kidney Foundation (2002) KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Disease, 39 (Suppl. 1), S1S266.
  • National Kidney Foundation (2006) KDOQI Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. American Journal of Kidney Disease, 47(Suppl. 3), S11S145.
  • Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T. & Kaplan, J. (2004) Hepcidin regulates cellular iron reflux by binding to ferroportin and inducing its internalisation. Science, 306, 20902093.
  • NICE (2006) Anaemia Management in People With Chronic Kidney Disease. Clinical guideline 39. National Institute for Health and Clinical Excellence, London.
  • NICE (2011) Anaemia Management in People With Chronic Kidney Disease. Clinical guideline 114. National Institute for Health and Clinical Excellence, London.
  • Peters, H.P., Rumjon, A., Bansal, S.S., Laarakkers, C.M., van den Brand, J.A., Sarafidis, P., Musto, R., Malyszko, J., Swinkels, D.W., Wetzels, J.F. & Macdougall, I.C. (2012) Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA. Nephrology, Dialysis, Transplantation, 27, 39233929.
  • Punnonen, K., Irjala, K. & Rajamaki, A. (1997) Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood, 89, 10521057.
  • Qunibi, W.Y., Martinez, C., Smith, M., Benjamin, J., Mangione, A. & Roger, S.D. (2010) A randomised controlled trial comparing intravenous ferric carboxymaltose with oral iron for the treatment of iron deficiency of non-dialysis dependent chronic kidney disease patients. Nephrology Dialysis Transplantation, 10, 19.
  • Rose, E.H., Abels, R.I., Nelson, R.A., McCullough, D.M. & Lessin, L. (1995) The use of rHuEPO in the treatment of anaemia related to myelodysplasia (MDS). British Journal of Haematology, 89, 831837.
  • Tessitore, N., Solero, G.P., Lippi, G., Bassi, A., Faccini, G.B., Bedogna, V., Gammaro, L., Brocco, G., Restivo, G., Bernich, P., Lupo, A. & Maschio, G. (2001) The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrology Dialysis Transplantation, 16, 14161423.
  • Tessitore, N., Girelli, D., Campostrini, N., Bedogna, V., Pietro Solero, G., Castagna, A., Melilli, E., Mantovani, W., De Matteis, G., Olivieri, O., Poli, A. & Lupo, A. (2010) Hepcidin is not useful as a biomarker for iron needs in hemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrology Dialysis Transplantation, 25, 39964002.
  • Thomas, C. & Thomas, L. (2002) Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clinical Chemistry, 48, 10661076.
  • Thomas, L., Franck, S., Messinger, M., Linssen, J., Thome, M. & Thomas, C. (2005) Reticulocyte hemoglobin measurement – comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clinical Chemistry Laboratory Medicine, 43, 11931202.
  • Thomas, C., Kirschbaum, A., Boehm, D. & Thomas, L. (2006) The diagnostic plot. A concept for identifying different states of iron deficiency and monitoring the response to epoietin therapy. Medical Oncology, 23, 2336.
  • Thorpe, S.J., Heath, A., Sharp, G., Cook, J., Ellis, R. & Worwood, M. (2010) A WHO reference reagent for the Serum Transferrin Receptor (sTfR): international collaborative study to evaluate a recombinant transferrin receptor preparation. Clinical Chemistry Laboratory Medicine, 48, 815820.
  • Urrechaga, E. (2009) Clinical utility of the new Beckman-Coulter parameter red blood cell size factor in the study of erythropoiesis. International Journal of Laboratory Haematology, 31, 623629.
  • Urrechaga, E. (2010) The new mature red cell parameter, low haemoglobin density, of the Beckman Coulter LH750: clinical utility in the diagnosis of iron deficiency. International Journal of Laboratory Haematology, 32, 144150.
  • Urrechaga, E., Borque, L. & Escanero, J.F. (2009) Potential utility of the new Sysmex XE 500 red blood cell extended parameters in the study of disorders of iron metabolism. Clinical Chemistry Laboratory Medicine, 47, 14111416.
  • Worwood, M. (1997) The laboratory assessment of iron status – an update. Clinica Chimica Acta, 259, 323.
  • van Wyck, D.B., Danielson, B.G. & Aronoff, G.R. (2004) Making sense: a scientific approach to intravenous iron therapy. Journal of The American Society of Nephrology, 15 (Suppl. 2), S91S92.